H.E. Prof. Sir Manuel Alejandro Freire-Garabal appointed with the Grand Cross of the Royal Order of Banu Assaf

H.E. Prof. Sir Manuel Alejandro Freire-Garabal has been appointed with the Grand Cross of the Royal Order of Banu Assaf during the Elite Global Family Offices and Private Investors Convened in Monaco at H.E. Sir Anthony Ritossa’s (15th Global Family Office Investment Summit for thought Leadership Exchanges on Legacy and Impact Investing).

He receives the highest honour of one of the most ancient orders of the Middle East according to his greatest achievements over more than 30 years of experience in the field of education and medicine.

His multiple contributions have changed significantly the life of future generations around the globe, mainly through his studies in the field of cancer research.

H.E. Prof. Sir Manuel Alejandro Freire-Garabal Núñez MD, Ph.D., FRSM, is a Full Professor of Pharmacology at the School of Medicine of the University of Santiago de Compostela (USC). Born in Spain, he has a Medical Degree (1986) and a PhD in Medicine (1989) from the University of Santiago de Compostela (USC).

He has acquired complementary education in Drug Discovery and Development, Global Health, Management, Organizations, Finances, Economy, Law and Cybersecurity.

Specialist in General Medicine by the Spanish Ministry of Health.
Currently, he is a Full Professor of Pharmacology at the School of Medicine of the University of Santiago de Compostela, lecturing in Pharmacology, Clinical Pharmacology and Therapeutics in the Degree of Medicine.

He also participates in Master courses (Research and Development of Medicines; Healthcare Management; Clinical and Social Gerontology), PhD training (Research and Development of Medicines; Comprehensive Healthcare; Clinical and Social Gerontology; Pharmacology; Clinical and Health Psychology) and other pre-and post-graduate educational activities (on Neurosciences, Mental Health, Stress and Health; Stress in high-Risk Professions; Training Course for caregivers of Mentally Handicapped; Nursing Training; Pharmaceutical Industry; Oncology; Translational Medicine; Emergency Medicine; etc.)

Director of the Stress and Neuroimmunology Laboratory research group, originally dedicated to Psycho-Neuro-Immunology, developing strategies to reduce the impact of stress and living conditions on cancer, infection and autoimmune diseases. Nowadays, he is more involved in the discovery and development of new drugs against cancer, immune diseases and infection, having obtained new compounds, of synthetic and natural origin – including some from the sea – that can be useful in future prostate and breast cancer treatment.

Authored +100 publications, addressed 23 PhD, and have participated with +200 lectures, keynotes and communications to scientific meetings worldwide, having received 15 national and international awards.

He was a member of the board of directors and advisor of several companies where he had the opportunity to create products and solutions, develop strategies and design performance improvements.

Currently, he is also involved in the design and development of artificial intelligence applied to healthcare and higher education.

He had international executive responsibilities in higher education, science, healthcare and entrepreneurship.

He was Advisor Responsible for International Relations of the USC for 10 years; during this time, he was in charge of the creation of one of the influential university international consortia in the world, the Compostela Group of Universities – still being a member of its executive committee – and in the organization of outstanding international programs and meetings.

Warmest congratulations on your achievement. We will never pay what you are doing for a Better World!